SCHEMBL5686275

SCHEMBL5686275

NC(=O)c1cncnc1Oc1cccc(-c2cc[nH]n2)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IKBKB O14920 1/20 0.38
▸ CHUK O15111 1/20 0.38
▸ NR1H2 P55055 5/20 0.37
▸ NR1H3 Q13133 4/20 0.37
▸ CDC7 O00311 1/20 0.36
▸ BTK Q06187 1/20 0.36
▸ F10 P00742 1/20 0.35
▸ GAA P10253 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ JAK2 O60674 1/20 0.35
▸ AURKA O14965 1/20 0.35
▸ MET P08581 1/20 0.35
▸ KDR P35968 1/20 0.35
▸ TEK Q02763 1/20 0.35
▸ AURKB Q96GD4 1/20 0.35
▸ RAB9A P51151 1/20 0.34
▸ PARP1 P09874 1/20 0.34
▸ SYK P43405 1/20 0.34
▸ PLAU P00749 1/20 0.34
▸ PDE4B Q07343 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2219515 0.76 CTNNB1 (0.50) BTKRAB9A
SCHEMBL28106186 0.74 PARP10 (0.50) BTKAURKARAB9ASYK
SCHEMBL28303592 0.71 CCNT1 (0.50) CDC7AURKAKDRAURKBPARP1
SCHEMBL27753623 0.69 PIK3CD (0.44) GAARAB9A
SCHEMBL9843467 0.69 LMNA (0.53) GAAMAPT
SCHEMBL24665285 0.68 LTA4H (0.41) PLAUEGFR
SCHEMBL30731795 0.68 LTA4H (0.41) PLAUEGFR
SCHEMBL26192798 0.66 ATM (0.44) KDRTEK
SCHEMBL8782192 0.66 IKBKB (0.53) IKBKBCHUKCDC7BTK
SCHEMBL31657673 0.66 MKNK1 (0.49) CDC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1648464-A1 2-AMINO-4-HYDROXY-5-PYRIMIDINCARBOXAMID DERIVATIVES AND RELATED COMPOUNDS AS T-CELL ACTIVATION INHIBITORS FOR THE TREATMENT OF INFLAMMATIONS AMGEN INC. (US) 2006-04-26 — — EP disclosed
WO-2005009443-A1 2-AMINO-4-HYDROXY-5-PYRIMIDINECARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS INHIBITORS OF T CELL ACTIVATION FOR THE TREATMENT OF INFLAMMATORY DISEASES AMGEN INC. (US) 2005-02-03 — — WO disclosed
Send feedback